Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
3417TSE Standard

OHKI HEALTHCARE HOLDINGS CO.,LTD.

大木ヘルスケアホールディングス Yahoo Finance

Recent & upcoming events

Aug 7
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Jun 23
Shareholder meeting Time TBD
Shareholders' meeting
Add to Google Calendar
May 15
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Sep 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Sep 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Oct 30
Est.
Earnings 2:00 approx.
Q2 earnings
Add to Google Calendar
2027
Jan 22
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
Mar 28
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Mar 29
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
Apr 16
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar
Jul 9
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar

KPI highlights

FY26
Revenue ¥360.36B YoY +3.1%
Operating income ¥719M margin 0.2%
Net income ¥1.34B YoY -49.3%
EPS ¥98 YoY -49.2%
P/E —
ROE 4.1% Equity ratio 23% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q1FY23 Q2FY23 Q3FY23 Q4FY24 Q1FY25 Q2
Revenue ¥74.84B¥81.42B¥85.82B¥85.43B¥81.99B—
Operating income ¥802M¥246M¥935M¥225M¥641M—
Net income ¥753M¥526M¥770M¥229M¥601M—
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2026）

事業法人 40.1%国内機関 8.2%個人 4.4%未開示 45.1%202120222023202420252026
事業法人国内機関海外機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

ロート製薬株式会社 12.9%ロート製薬株式会社東邦ホールディングス株式会社 10.4%東邦ホールディングス株式会社国分グループ本社株式会社 7.3%国分グループ本社株式会社大木ヘルスケアホールディングス取引先 4.4%大木ヘルスケアホールディングス取引先持株会株式会社三菱ＵＦＪ銀行 4.2%株式会社三菱ＵＦＪ銀行株式会社ツムラ 4.1%株式会社ツムラ日本証券金融株式会社 4%日本証券金融株式会社久光製薬株式会社 3%久光製薬株式会社株式会社明治 2.3%株式会社明治ＤＢＳ　ＢＡＮＫ　ＬＴＤ　７００１７ 2.2%ＤＢＳ　ＢＡＮＫ　ＬＴＤ　７００１７０（常任代理人 株式会社みずほ銀行決済営業部）202120222023202420252026

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
ロート製薬株式会社 1,759,000 12.9% Yuho (EDINET)
東邦ホールディングス株式会社 1,413,000 10.4% Yuho (EDINET)
国分グループ本社株式会社 1,000,000 7.3% Yuho (EDINET)
大木ヘルスケアホールディングス取引先持株会 605,000 4.4% Yuho (EDINET)
株式会社三菱UFJ銀行 567,000 4.2% Yuho (EDINET)
株式会社ツムラ 559,000 4.1% Yuho (EDINET)
日本証券金融株式会社 548,000 4.0% Yuho (EDINET)
久光製薬株式会社 412,000 3.0% Yuho (EDINET)
株式会社明治 318,000 2.3% Yuho (EDINET)
DBS BANK LTD 700170 300,000 2.2% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

4/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 0.9%
✗ Positive operating cash flow ¥-1.42B
✗ ROA improved YoY 1.9% → 0.9%
✗ Operating CF exceeds net income (accrual quality) OCF ¥-1.42B / net income ¥1.34B
✓ Equity ratio improved* Substitute for the original “decrease in long-term debt” 22.2% → 23.0%
✓ Current ratio improved 1.14× → 1.14×
✓ No dilution (shares outstanding did not increase) 14,072,100 → 14,072,100
✗ Gross margin improved 5.3% → 4.9%
✗ Asset turnover improved 2.51× → 2.43×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio 23.0%
Current ratio 1.1×
Years of positive operating CF 5 of last 10 yrs
Payout ratio 143%
Latest fiscal year result Profit (net income ¥1.34B)

Performance history

Last 10 years
0億円901億円1,802億円2,703億円3,604億円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 2,2232,3952,5852,7732,8622,7823,0443,3473,4953,604
Operating income 13.023.420.422.430.16.3120.620.427.77.19
Ordinary income 22.133.031.232.041.115.831.532.639.919.6
Net income 7.5923.120.523.728.09.7221.822.126.413.4
Total assets 8489661,0041,0181,0731,1401,2251,3861,3931,484
Equity 138167175193224221243279311342

Indicators & cash flow

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ¥54¥165¥147¥171¥203¥71¥158¥160¥193¥98
ROE 5.8%15.2%12.0%12.9%13.5%4.4%9.5%8.5%9.0%4.1%
Operating CF -6.3655.927.3-9.01-42.713.10.9675.5-91.8-14.2
Investing CF -2.07-14.7-4.59-4.617.100.68-2.91-4.96-31.3-6.71
Financing CF -0.11-16.5-12.6-6.0823.6-14.06.81-20.068.914.2
FCF -8.4341.222.7-13.6-35.613.8-1.9570.5-123-20.9

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Key financial metrics

3-year revenue growth ✓ Dividend grower ✓

Sector positioning

Relative standing within the sector

IR disclosure history

Timely disclosures & annual reports
Is this information incorrect?

Data provided by Twelve Data